FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/10/074698 [Registered on: 03/10/2024] Trial Registered Prospectively
Last Modified On: 28/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To Compare effect of TRIPHALA-NIMBADI Churna and NISHAMALAKI Churna in diabetes. 
Scientific Title of Study   An etiopathological study of madhumeha w.s.r. to diabetes mellitus type 2 and evaluation of comparative therapeutical effect of TRIPHALA-NIMBADI Churna(KALPIT) and NISHAMALAKI Churna. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Gopal Singh Bithu 
Designation  PG Scholar 
Affiliation  Madan Mohan Malviya Govt Ayurved College 
Address  OPD no.4 PG Department of Rog Nidan evum Vikriti Vigyan Madan Mohan Malviya Govt Ayurved College, near radaji circle Udaipur.Rajasthan PIN 313001

Udaipur
RAJASTHAN
313001
India 
Phone  8949849430  
Fax    
Email  gopalsinghbithu000@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Man Mohan Sharma 
Designation  Professor & HOD 
Affiliation  Madan Mohan Malviya Govt Ayurved College 
Address  OPD no.4 PG Department of Rog Nidan evum Vikriti Vigyan Madan Mohan Malviya Govt Ayurved College, near radaji circle Udaipur.Rajasthan PIN 313001

Udaipur
RAJASTHAN
313001
India 
Phone  9887364809  
Fax    
Email  drmmsharma72@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Man Mohan Sharma 
Designation  Professor & HOD 
Affiliation  Madan Mohan Malviya Govt Ayurved College 
Address  OPD no.4 PG Department of Rog Nidan evum Vikriti Vigyan Madan Mohan Malviya Govt Ayurved College, near radaji circle Udaipur.Rajasthan PIN 313001

Udaipur
RAJASTHAN
313001
India 
Phone  9887364809  
Fax    
Email  drmmsharma72@gmail.com  
 
Source of Monetary or Material Support  
Madan Mohan Malviya Govt Ayurved College Udaipur Rajasthan PIN 313001 
 
Primary Sponsor  
Name  Madan Mohan Malviya Govt Ayurved College Udaipur 
Address  Madan Mohan Malviya Govt Ayurved College, near radaji circle Udaipur.Rajasthan PIN 313001 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Gopal Singh Bithu  Madan Mohan Malviya Govt. Ayurved College Hospital Udaipur   OPD no.4 PG Department of Rog Nidan evum Vikriti Vigyan Madan Mohan Malviya Govt Ayurved College, near radaji circle Udaipur.Rajasthan PIN 313001
Udaipur
RAJASTHAN 
8949849430

gopalsinghbithu000@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE M.M.M. GOVT. AYURVED COLLEGE AMBAMATA UDAIPUR (RAJ)  Approved 
INSTITUTIONAL ETHICS COMMITTEE M.M.M. GOVT.AYURVED COLLEGE UDAIPUR  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E118||Type 2 diabetes mellitus with unspecified complications. Ayurveda Condition: MADHUMEHAH/KSHAUDRAMEHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugOther than Classical(1) Medicine Name: Triphala-Nimbadi Churna, Reference: NA, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 2 Months, anupAna/sahapAna: Yes(details: -Lukewarm Water), Additional Information: NIL
2Comparator ArmDrugClassical(1) Medicine Name: Nishamalaki Churna, Reference: Ashtang Hriday Uttar Tantra 40/48 , Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 2 Months, anupAna/sahapAna: Yes(details: Lukewarm Water), Additional Information: Nil
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1.Patient having clinical signs and symtoms of diabetes mellitus type 2.
2.Patient having fasting blood sugar level between 126-300 mg/dl and post prandial blood sugar level 200-400 mg/dl. 
 
ExclusionCriteria 
Details  1.Patient of type 1 diabetes.
2.Patient with gestational and drug induced diabetes mellitus.
3.Patient with severe systemic diseases and lactating mothers. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1. Improvement in signs and symptoms of Madhumeha(Diabetes Mellitus)
2. Lower down of blood sugar level to healthy range. 
60 days 
 
Secondary Outcome  
Outcome  TimePoints 
1. Improvement in signs and symptoms of Madhumeha(Diabetes Mellitus)
2. Lower down of blood sugar level to healthy range. 
20th day , 40th day ,60th day 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   16/12/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is  a clinical trial to evaluate the comparative therapeutical effect of TRIPHALA-NIMBADI Churna (KALPIT) and NISHAMALAKI Churna in madhumeha (Diabetes mellitus type 2).In this study 20 patient will be administered with TRIPHALA-NIMBADI Churna and other 20 patients will be administered with NISHAMALAKI Churna.Dose of both drug will be 3gm twice a day with lukewarm water after meal. 
Close